{"id":"https://openalex.org/W7224096372","doi":"https://doi.org/10.13429/j.cnki.cjcr.2026.10.014","title":"Predictive value of a combined model based on immune indicators and clinical characteristics for the prognosis of patients with primary myelofibrosis","display_name":"Predictive value of a combined model based on immune indicators and clinical characteristics for the prognosis of patients with primary myelofibrosis","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7224096372","doi":"https://doi.org/10.13429/j.cnki.cjcr.2026.10.014"},"language":"zh","primary_location":{"id":"pmh:oai:doaj.org/article:a8c2a95635274d4ebcce5da02cd4ddb9","doi":"https://doi.org/10.13429/j.cnki.cjcr.2026.10.014","is_oa":false,"landing_page_url":"https://doaj.org/article/a8c2a95635274d4ebcce5da02cd4ddb9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo linchuang yanjiu, Vol 39, Iss 10, Pp 1542-1545,1550 (2026)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160016728","display_name":"TIAN Juan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TIAN Juan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086578704","display_name":"Yimiao Xue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"XUE Yimiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160014768","display_name":"WEI Yuping","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"WEI Yuping","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135244481","display_name":"GU Yihai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"GU Yihai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5160060273","display_name":"SONG Lijun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SONG Lijun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84053731,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":1.0},{"id":"https://openalex.org/keywords/prognosis-prediction","display_name":"outcome prediction","score":0.8450000286102295},{"id":"https://openalex.org/keywords/prognostic-model","display_name":"prognostic model","score":0.8450000286102295},{"id":"https://openalex.org/keywords/immune-markers","display_name":"immunological markers","score":0.8970000147819519},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9670000076293945},{"id":"https://openalex.org/keywords/iga","display_name":"IgA","score":0.7820000052452087},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.8740000128746033},{"id":"https://openalex.org/keywords/transfusion-dependence","display_name":"transfusion dependence","score":0.9100000262260437},{"id":"https://openalex.org/keywords/international-prognostic-scoring-system","display_name":"International Prognostic Scoring System","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8050000071525574},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8029999732971191},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.7789999842643738},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9520000219345093},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.9168999791145325},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8163999915122986},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.753600001335144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6898000240325928},{"id":"https://openalex.org/C58471807","wikidata":"https://www.wikidata.org/wiki/Q327120","display_name":"Receiver operating characteristic","level":2,"score":0.6032999753952026},{"id":"https://openalex.org/C3019719930","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value","level":2,"score":0.5476999878883362},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.5015000104904175},{"id":"https://openalex.org/C2993277928","wikidata":"https://www.wikidata.org/wiki/Q7248370","display_name":"Prognostic model","level":3,"score":0.453900009393692},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4316999912261963},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.42489999532699585},{"id":"https://openalex.org/C161584116","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate statistics","level":2,"score":0.42260000109672546},{"id":"https://openalex.org/C198433322","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value of tests","level":2,"score":0.42100000381469727},{"id":"https://openalex.org/C152877465","wikidata":"https://www.wikidata.org/wiki/Q208042","display_name":"Regression analysis","level":2,"score":0.36719998717308044},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.34929999709129333},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3122999966144562},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2985000014305115},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2856999933719635},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.2822999954223633},{"id":"https://openalex.org/C2992282259","wikidata":"https://www.wikidata.org/wiki/Q3149136","display_name":"Immune status","level":3,"score":0.2800000011920929},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.27950000762939453},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.2768000066280365},{"id":"https://openalex.org/C3020225094","wikidata":"https://www.wikidata.org/wiki/Q80091","display_name":"Area under curve","level":3,"score":0.2732999920845032},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.2648000121116638},{"id":"https://openalex.org/C2984538763","wikidata":"https://www.wikidata.org/wiki/Q2260590","display_name":"Scoring system","level":2,"score":0.26249998807907104},{"id":"https://openalex.org/C83546350","wikidata":"https://www.wikidata.org/wiki/Q1139051","display_name":"Regression","level":2,"score":0.2556999921798706},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.2526000142097473},{"id":"https://openalex.org/C53789813","wikidata":"https://www.wikidata.org/wiki/Q3553769","display_name":"Positive predicative value","level":3,"score":0.25029999017715454}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:a8c2a95635274d4ebcce5da02cd4ddb9","doi":"https://doi.org/10.13429/j.cnki.cjcr.2026.10.014","is_oa":false,"landing_page_url":"https://doaj.org/article/a8c2a95635274d4ebcce5da02cd4ddb9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Zhongguo linchuang yanjiu, Vol 39, Iss 10, Pp 1542-1545,1550 (2026)","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4241718608","https://openalex.org/W2966164887","https://openalex.org/W2912302259","https://openalex.org/W2094267313","https://openalex.org/W3083720543","https://openalex.org/W2045831870","https://openalex.org/W2008799537","https://openalex.org/W2270159550","https://openalex.org/W2127559749","https://openalex.org/W4221039767"],"abstract_inverted_index":{"Objective":[0],"To":[1],"explore":[2],"the":[3,21,44,62,86,105,117,120,124,139,154,232,236,282],"construction":[4],"of":[5,23,37,47,104,126,138,167,174,183,188,206,235,251,281,284],"a":[6,76,80,130,248,275],"combined":[7,131,140,220,237,257],"model":[8,132,141,222,239,258],"based":[9,260],"on":[10,261],"immune":[11,92,262],"indicators":[12,122,263],"and":[13,16,32,123,148,264,271],"clinical":[14,102,265,269,279],"characteristics":[15,266],"its":[17],"value":[18,250,270],"in":[19,165,215],"predicting":[20],"prognosis":[22,78,82,125,156,159,214,283],"patients":[24,39,65,87,127,216,285],"with":[25,40,128,153,212,217,253,286],"primary":[26],"myelofibrosis(PMF),to":[27],"support":[28],"precise":[29],"risk":[30],"stratification":[31],"management.":[33],"Methods":[34],"A":[35],"total":[36],"71":[38],"PMF":[41],"treated":[42],"at":[43],"People's":[45],"Hospital":[46],"Ningxia":[48],"Hui":[49],"Autonomous":[50],"Region":[51],"from":[52],"January":[53],"2016":[54],"to":[55,84,115],"June":[56],"2024":[57],"were":[58,66,73,108,209],"retrospectively":[59],"selected":[60],"as":[61,274],"research":[63],"subjects.All":[64],"followed":[67],"up":[68],"for":[69,278],"1":[70],"year.":[71],"Patients":[72],"divided":[74],"into":[75],"good":[77,155],"group(n=51)and":[79],"poor":[81,158,213],"group(n=20)according":[83],"whether":[85],"deteriorated,relapsed":[88],"or":[89],"died.":[90],"The":[91,135,219,244,256],"indicators\uff3bCD4+":[93],"T":[94,96,185],"cells,CD8+":[95],"cells,interleukin":[97],"-":[98,100],"6(IL":[99],"6),immunoglobulin(Ig)G,IgA,IgM\uff3dand":[101],"data":[103],"two":[106],"groups":[107],"compared.":[109],"Logistic":[110],"regression":[111,195],"analysis":[112,196],"was":[113,133,142,223,240],"used":[114],"examine":[116],"relationship":[118],"between":[119],"above":[121],"PMF,and":[129],"constructed.":[134],"predictive":[136,221,238],"performance":[137],"evaluated":[143],"using":[144],"receiver":[145],"operating":[146],"characteristic(ROC)curve":[147],"Hosmer-Lemeshow":[149,245],"goodness-of-fit":[150],"test.Results":[151],"Compared":[152],"group,the":[157],"group":[160],"had":[161],"statistically":[162],"significant":[163],"differences":[164],"age,score":[166],"International":[168],"Prognostic":[169],"Scoring":[170],"System(IPSS),transfusion":[171],"dependence":[172],"ratio,score":[173],"Myeloproliferative":[175],"Neoplasm":[176],"Symptom":[177,181],"Assessment":[178],"Form":[179],"Total":[180],"Score(MPN-10),percentage":[182],"CD4+":[184],"cells,and":[186],"levels":[187,205],"IL-6,C-reactive":[189],"protein(CRP),lactate":[190],"dehydrogenase(LDH)and":[191],"IgA(P<0.05).":[192],"Multivariate":[193],"logistic":[194],"showed":[197],"that":[198],"an":[199],"IPSS":[200],"score":[201],"\u22653,transfusion":[202],"dependence,and":[203],"elevated":[204],"IL-6,LDH,and":[207],"IgA":[208],"independently":[210],"associated":[211],"PMF(P<0.05).":[218],"expressed":[224],"as:logit(P)=":[225],"-6.856+0.812\u00d7IPSS":[226],"score(\u22653":[227],"points)+1.008\u00d7transfusion":[228],"dependence+0.383\u00d7IL-6+0.008\u00d7LDH+0.820\u00d7IgA.The":[229],"area":[230],"under":[231],"ROC":[233],"curve":[234],"0.923(95%":[241],"CI:0.860-":[242],"0.985).":[243],"test":[246],"yielded":[247],"\u03c72":[249],"4.812":[252],"P=0.777.":[254],"Conclusion":[255],"constructed":[259],"has":[267],"certain":[268],"holds":[272],"promise":[273],"potential":[276],"biomarker":[277],"assessment":[280],"PMF.":[287]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-29T00:00:00"}